4DX:ASX
4DMedical Ltd
A$3.44
arrow_upward
+1.47%(+0.050) 1D
Sep 3, 12:46:35 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4DX...
Open
A$3.44
High
A$3.51
Low
A$3.40
Mkt. cap
2.06B
Avg. vol.
4.53M
Volume
1.69M
52-wk high
A$7.55
52-wk low
A$0.83
EPS
-A$0.34
Shares outstanding
599.93M
No. of employees
124
Open
A$3.44
High
A$3.51
Low
A$3.40
Mkt. cap
2.06B
Avg. vol.
4.53M
Volume
1.69M
52-wk high
A$7.55
52-wk low
A$0.83
EPS
-A$0.34
Shares outstanding
599.93M
No. of employees
124
News stories
From web sources and news partners
TheBull.com.au
·
2 days ago
4DMedical Shares Close Out Volatile Month Negative, As Resistance Shapes Up
Profile
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
About 4DMedical Ltd
AI content may include mistakes. Learn more